Conditional Immune Escape during Chronic Simian Immunodeficiency Virus Infection
- PMID: 26491171
- PMCID: PMC4702533
- DOI: 10.1128/JVI.02587-15
Conditional Immune Escape during Chronic Simian Immunodeficiency Virus Infection
Abstract
Anti-HIV CD8 T cells included in therapeutic treatments will need to target epitopes that do not accumulate escape mutations. Identifying the epitopes that do not accumulate variants but retain immunogenicity depends on both host major histocompatibility complex (MHC) genetics and the likelihood for an epitope to tolerate variation. We previously found that immune escape during acute SIV infection is conditional; the accumulation of mutations in T cell epitopes is limited, and the rate of accumulation depends on the number of epitopes being targeted. We have now tested the hypothesis that conditional immune escape extends into chronic SIV infection and that epitopes with a preserved wild-type sequence have the potential to elicit epitope-specific CD8 T cells. We deep sequenced simian immunodeficiency virus (SIV) from Mauritian cynomolgus macaques (MCMs) that were homozygous and heterozygous for the M3 MHC haplotype and had been infected with SIV for about 1 year. When interrogating variation within individual epitopes restricted by M3 MHC alleles, we found three categories of epitopes, which we called categories A, B, and C. Category B epitopes readily accumulated variants in M3-homozygous MCMs, but this was less common in M3-heterozygous MCMs. We then determined that chronic CD8 T cells specific for these epitopes were more likely preserved in the M3-heterozygous MCMs than M3-homozygous MCMs. We provide evidence that epitopes known to escape from chronic CD8 T cell responses in animals that are homozygous for a set of MHC alleles are preserved and retain immunogenicity in a host that is heterozygous for the same MHC alleles.
Importance: Anti-HIV CD8 T cells that are part of therapeutic treatments will need to target epitopes that do not accumulate escape mutations. Defining these epitope sequences is a necessary precursor to designing approaches that enhance the functionality of CD8 T cells with the potential to control virus replication during chronic infection or after reactivation of latent virus. Using MHC-homozygous and -heterozygous Mauritian cynomolgus macaques, we have now obtained evidence that epitopes known to escape from chronic CD8 T cell responses in animals that are MHC homozygous are preserved and retain immunogenicity in a host that is heterozygous for the same MHC alleles. Importantly, our findings support the conditional immune escape hypothesis, such that the potential to present a greater number of CD8 T cell epitopes within a single animal can delay immune escape in targeted epitopes. As a result, certain epitope sequences can retain immunogenicity into chronic infection.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Similar articles
-
Acute-Phase CD4+ T Cell Responses Targeting Invariant Viral Regions Are Associated with Control of Live Attenuated Simian Immunodeficiency Virus.J Virol. 2018 Oct 12;92(21):e00830-18. doi: 10.1128/JVI.00830-18. Print 2018 Nov 1. J Virol. 2018. PMID: 30111562 Free PMC article.
-
Acute-phase CD8 T cell responses that select for escape variants are needed to control live attenuated simian immunodeficiency virus.J Virol. 2013 Aug;87(16):9353-64. doi: 10.1128/JVI.00909-13. Epub 2013 Jun 19. J Virol. 2013. PMID: 23785211 Free PMC article.
-
MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques.Sci Transl Med. 2010 Mar 10;2(22):22ra18. doi: 10.1126/scitranslmed.3000524. Sci Transl Med. 2010. PMID: 20375000 Free PMC article.
-
A 30-year journey of trial and error towards a tolerogenic AIDS vaccine.Arch Virol. 2018 Aug;163(8):2025-2031. doi: 10.1007/s00705-018-3936-1. Epub 2018 Jul 24. Arch Virol. 2018. PMID: 30043201 Free PMC article. Review.
-
Making the animal model for AIDS research more precise: the impact of major histocompatibility complex (MHC) genes on pathogenesis and disease progression in SIV-infected monkeys.Curr Mol Med. 2001 Sep;1(4):515-22. doi: 10.2174/1566524013363555. Curr Mol Med. 2001. PMID: 11899095 Review.
Cited by
-
Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV.J Virol. 2016 May 27;90(12):5541-5548. doi: 10.1128/JVI.00192-16. Print 2016 Jun 15. J Virol. 2016. PMID: 26962218 Free PMC article.
-
The Cynomolgus Macaque MHC Polymorphism in Experimental Medicine.Cells. 2019 Aug 26;8(9):978. doi: 10.3390/cells8090978. Cells. 2019. PMID: 31455025 Free PMC article. Review.
-
The mucosal barrier and anti-viral immune responses can eliminate portions of the viral population during transmission and early viral growth.PLoS One. 2021 Dec 2;16(12):e0260010. doi: 10.1371/journal.pone.0260010. eCollection 2021. PLoS One. 2021. PMID: 34855793 Free PMC article.
-
Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques.PLoS Negl Trop Dis. 2016 Dec 2;10(12):e0005168. doi: 10.1371/journal.pntd.0005168. eCollection 2016 Dec. PLoS Negl Trop Dis. 2016. PMID: 27911897 Free PMC article.
-
Acute-Phase CD4+ T Cell Responses Targeting Invariant Viral Regions Are Associated with Control of Live Attenuated Simian Immunodeficiency Virus.J Virol. 2018 Oct 12;92(21):e00830-18. doi: 10.1128/JVI.00830-18. Print 2018 Nov 1. J Virol. 2018. PMID: 30111562 Free PMC article.
References
-
- O'Connor DH, McDermott AB, Krebs KC, Dodds EJ, Miller JE, Gonzalez EJ, Jacoby TJ, Yant L, Piontkivska H, Pantophlet R, Burton DR, Rehrauer WM, Wilson N, Hughes AL, Watkins DI. 2004. A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation. J Virol 78:14012–14022. doi:10.1128/JVI.78.24.14012-14022.2004. - DOI - PMC - PubMed
-
- Deng K, Pertea M, Rongvaux A, Wang L, Durand CM, Ghiaur G, Lai J, McHugh HL, Hao H, Zhang H, Margolick JB, Gurer C, Murphy AJ, Valenzuela DM, Yancopoulos GD, Deeks SG, Strowig T, Kumar P, Siliciano JD, Salzberg SL, Flavell RA, Shan L, Siliciano RF. 2015. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature 517:381–385. doi:10.1038/nature14053. - DOI - PMC - PubMed
-
- Kulkarni V, Valentin A, Rosati M, Alicea C, Singh AK, Jalah R, Broderick KE, Sardesai NY, Le Gall S, Mothe B, Brander C, Rolland M, Mullins JI, Pavlakis GN, Felber BK. 2014. Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques. PLoS One 9:e86254. doi:10.1371/journal.pone.0086254. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials